
Rutland reaps 2.6x on Advantage Healthcare sale
Rutland Partners has sold UK-based Advantage Healthcare to trade buyer Interserve for £26.5m, making a 2.6x money multiple on its original investment.
The deal was completed in December 2012. Rutland acquired the company for an overall consideration of £10.5m in March 2005. The transaction was financed with a £5m debt package from Lloyds, including a term loan and invoice discounting facilities. Rutland committed £5.5m in equity as part of the deal. The company was then trading as BUPA Healthcare Professionals.
Over the course of 2012, Rutland divested three other portfolio companies – NoteMachine, Pule Home Products and Attends Healthcare – returning an overall £190m to its investors.
Company
Advantage Healthcare is a British provider of home healthcare services to both public and private organisations and individuals. It operates a network of 27 outlets across the UK.
In 2012, the company's sales amounted to £41m, with an EBITDA of around £3m.
People
Rutland managing director Nick Morrill and partner Oliver Jones led the deal on behalf of the seller. Phil Burrows is the managing director of Advantage Healthcare and Adrian Ringrose is CEO of Interserve.
Advisers
Company – Walker Morris (Legal).
Vendor – PwC (M&A); Eversheds (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater